The inflammatory injury of microglia involved in Tourette syndrome development
DOI:
https://doi.org/10.61173/hex2ak76Keywords:
Tourette Syndrome, Puerarin, Microglia, neuroinflammationAbstract
Tourette Syndrome (TS), a chronic neuroinflammatory disorder, is characterized by motor and vocal tics. Microglial inflammatory activity in TS is increased, while microglial-mediated clearance mechanisms are compromised. Our study aimed to investigate the effect of puerarin on microglial inflammation. Our study confirmed that 20 mg/mL of puerarin was the optimal intervention concentration by CCK8 analysis. Furthermore, we found that puerarin could inhibit proinflammatory factors and up-regulate anti-inflammatory factors at the protein and mRNA levels, thus playing a role in regulating microglial inflammation. This study provides a new strategy for regulating neuroinflammation in TS.
References
[1] Müller, N. (2007, June 30). Tourette’s syndrome: clinical features, pathophysiology, and therapeutic approaches. Dialogues in Clinical Neuroscience, 9(2), 161–171. https://doi. org/10.31887/dcns.2007.9.2/nmueller
[2] Efron, D., & Dale, R. C. (2018, October). Tics and Tourette syndrome. Journal of Paediatrics and Child Health, 54(10), 1148–1153. https://doi.org/10.1111/jpc.14165
[3] Set, K. K., & Warner, J. N. (2021, July). Tourette syndrome in children: An update. Current Problems in Pediatric and Adolescent Health Care, 51(7), 101032. https://doi.org/10.1016/ j.cppeds.2021.101032
[4] Streit, W.J., Mrak, R.E. & Griffin, W.S.T. Microglia and neuroinflammation: a pathological perspective. J Neuroinflammation 1, 14 (2004). https://doi.org/10.1186/1742- 2094-1-14
[5] Paschou, P., Fernandez, T. V., Sharp, F., Heiman, G. A., & Hoekstra, P. J. (2013). Genetic susceptibility and neurotransmitters in Tourette syndrome. International review of neurobiology, 112, 155–177. https://doi.org/10.1016/B978-0-12- 411546-0.00006-8
[6] Efron, D., & Dale, R. C. (2018, October). Tics and Tourette syndrome. Journal of Paediatrics and Child Health, 54(10), 1148–1153. https://doi.org/10.1111/jpc.14165
[7] Guo, S., Wang, H., & Yin, Y. (2022). Microglia Polarization From M1 to M2 in Neurodegenerative Diseases. Frontiers in aging neuroscience, 14, 815347. https://doi.org/10.3389/ fnagi.2022.815347
[8] Orihuela, R., McPherson, C. A., & Harry, G. J. (2015, May 11). Microglial M1/M2 polarization and metabolic states. British Journal of Pharmacology, 173(4), 649–665. https://doi. org/10.1111/bph.13139
[9] Colonna, M., & Butovsky, O. (2017). Microglia Function in the Central Nervous System During Health and Neurodegeneration. Annual review of immunology, 35, 441– 468. https://doi.org/10.1146/annurev-immunol-051116-052358
[10] Zhou, Y. X., Zhang, H., & Peng, C. (2014). Puerarin: a review of pharmacological effects. Phytotherapy research: PTR, 28(7), 961–975. https://doi.org/10.1002/ptr.5083
[11] Li, L., Wang, Y., Wang, H., Lv, L., & Zhu, Z. (2020, February 16). Metabolic responses of BV‐2 cells to puerarin on its polarization using ultra‐performance liquid chromatography– mass spectrometry. Biomedical Chromatography, 34(4). https:// doi.org/10.1002/bmc.4796
Downloads
Published
Issue
Section
License
Copyright (c) 2023 by the authors.
This work is licensed under a Creative Commons Attribution 4.0 International License.
